3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
2
Stroke
1
Recurrence
1
Ovarian Neoplasms
1
Neurologic Manifestations
1
Melanoma
1
Margins of Excision
1
Malignant Solid Neoplasm
1
Malignant Female Reproductive System Neoplasm
1
Inflammatory Breast Neoplasms
1
Glioblastoma
1
Fallopian Tube Neoplasms
1
Communication
1
Colorectal Neoplasms
1
Caregiver Burden
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms
1
Brain Neoplasms
1
Brain Injuries, Traumatic
1
Brain Injuries
1
Advanced Malignant Solid Neoplasm
1
Interventions
Nivolumab
21
cabozantinib
12
Specimen Handling
11
Ipilimumab
10
belzutifan
9
pembrolizumab
8
Magnetic Resonance Spectroscopy
8
CTLA-4 Antigen
5
Biopsy
5
Axitinib
5
lenvatinib
4
Sunitinib
4
Immunoglobulin G
3
Disulfides
3
zimberelimab
2
tivozanib
2
relatlimab
2
pazopanib
2
palbociclib
2
atezolizumab
2
aldesleukin
2
X-Rays
2
Watchful Waiting
2
Radiosurgery
2
Nephrectomy
2
Bevacizumab
2
ulixertinib
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
trametinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
Palliative Care
×
30 days
×
Clear all
No trials found.